Citation: I. Kishimoto et al., A genetic model provides evidence that the receptor for atrial natriureticpeptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy, P NAS US, 98(5), 2001, pp. 2703-2706
Authors:
Izumi, T
Saito, Y
Kishimoto, I
Harada, M
Kuwahara, K
Hamanaka, I
Takahashi, N
Kawakami, R
Li, YH
Takemura, G
Fujiwara, H
Garbers, DL
Mochizuki, S
Nakao, K
Citation: T. Izumi et al., Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappa B activation and alleviates myocardial ischemia/reperfusion injury, J CLIN INV, 108(2), 2001, pp. 203-213
Citation: I. Kishimoto et al., Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing, CAN J PHYSL, 79(8), 2001, pp. 715-722
Authors:
Dubois, SK
Kishimoto, I
Lillis, TO
Garbers, DL
Citation: Sk. Dubois et al., A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function, P NAS US, 97(8), 2000, pp. 4369-4373
Authors:
Chusho, H
Ogawa, Y
Tamura, N
Suda, M
Yasoda, A
Miyazawa, T
Kiskimoto, I
Komatsu, Y
Itoh, H
Tanaka, K
Saito, Y
Garbers, DL
Nakao, K
Citation: H. Chusho et al., Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways, ENDOCRINOL, 141(10), 2000, pp. 3807-3813
Citation: Rb. Yang et al., Disruption of a retinal guanylyl cyclase gene leads to cone-specific dystrophy and paradoxical rod behavior, J NEUROSC, 19(14), 1999, pp. 5889-5897